Chickasaw Capital Management LLC Pfizer Inc Transaction History

Chickasaw Capital Management LLC

$2.25 Billion
Q2 2024

A detailed history of Chickasaw Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Chickasaw Capital Management LLC holds 7,460 shares of PFE stock, worth $221,263. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,460

Previous 7,460 -0.0%

Holding current value

$221,263

Previous $207,000 0.97%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$26.13 - $33.94 $213,743 - $277,629	-8,180 Reduced 52.3%	7,460 $215,000
Q4 2022 Jan 10, 2023	SELL	$41.75 - $54.5 $26,928 - $35,152	-645 Reduced 3.96%	15,640 $801,000
Q1 2022 Apr 14, 2022	SELL	$45.75 - $56.69 $9,150 - $11,338	-200 Reduced 1.21%	16,285 $843,000
Q4 2021 Jan 11, 2022	SELL	$41.32 - $61.25 $53,716 - $79,625	-1,300 Reduced 7.31%	16,485 $973,000
Q2 2021 Jul 13, 2021	BUY	$35.91 - $40.68 $184,756 - $209,298	5,145 Added 40.7%	17,785 $696,000
Q1 2021 Apr 01, 2021	SELL	$33.49 - $37.77 $4,521 - $5,098	-135 Reduced 1.06%	12,640 $458,000
Q4 2020 Jan 12, 2021	BUY	$33.47 - $42.56 $87,022 - $110,656	2,600 Added 25.55%	12,775 $470,000
Q3 2020 Oct 08, 2020	BUY	$31.75 - $37.25 $323,056 - $379,018	10,175 New	10,175 $373,000
Q1 2020 Apr 06, 2020	SELL	$27.03 - $38.62 $153,395 - $219,168	-5,675 Closed	0 $0
Q4 2018 Jan 11, 2019	SELL	$38.47 - $43.86 $230,820 - $263,160	-6,000 Reduced 51.39%	5,675 $248,000
Q2 2018 Jul 23, 2018	BUY	$32.98 - $35.16 $164,899 - $175,799	5,000 Added 74.91%	11,675 $424,000
Q3 2017 Oct 16, 2017	BUY	$31.0 - $34.15 $206,925 - $227,951	6,675	6,675 $238,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chickasaw Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chickasaw Capital Management LLC with notifications on news.

Account

Chickasaw Capital Management LLC Pfizer Inc Transaction History